Hypertrophic CardiomyopathyReferencesCitationsWynne J, Braunwald E (2004). The cardiomyopathies. In
DP Zipes et al., eds., Braunwald's Heart Disease, 7th
ed., pp. 1659–1696. Philadelphia: Elsevier Saunders. Maron BJ, et al. (2003). American College of
Cardiology/European Society of Cardiology clinical expert consensus document on
hypertrophic cardiomyopathy. Journal of the American College of
Cardiology, 42(9): 1–27. Maron BJ (2002). Hypertrophic cardiomyopathy: A systematic review. JAMA, 287(10): 1312–1320. Nishimura RA, et al. (2004). Hypertrophic
cardiomyopathy. In V Fuster et al., eds., Hurst's the
Heart, 11th ed., pp. 1909–1936. New York: McGraw-Hill Medical Publishing
Division. Maron BJ, et al. (1999). Clinical course of hypertrophic cardiomyopathy
in a regional United States cohort. JAMA, 281(7): 650–655. Maron BJ, et al. (2000). Efficacy of implantable cardioverter-defibrillators
for the prevention of sudden death in patients with hypertrophic cardiomyopathy. New
England Journal of Medicine, 342(6): 365–373.
Other Works ConsultedMaron BJ, et al. (1999). Assessment of permanent
dual-chamber pacing as a treatment for drug-refractory symptomatic patients
with obstructive hypertrophic cardiomyopathy. Circulation, 99(22): 2927–2933. O'Rourke RA (1999). Cardiac pacing: An alternative
treatment for selected patients with hypertrophic cardiomyopathy and adjunctive
therapy for certain patients with dilated cardiomyopathy. Circulation, 100(8): 786–788. Roberts R, Sigwart U (2005). Current concepts of the
pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation, 112(2): 293–296. Spirito P, Maron BJ (1999). Perspectives on the role
of new treatment strategies in hypertrophic obstructive cardiomyopathy. Journal of the American College of Cardiology, 33(4): 1071–1075. Watkins H (2000). Sudden death
in hypertrophic cardiomyopathy. New England
Journal of Medicine, 342(6): 422–423. Winakur S, Jessup M (2004). Heart failure. In DC Dale,
DD Federman, eds., ACP Medicine, section 1, chap. 2. New
York: WebMD.
| |